24 May 2013
Keywords: ec, oks, new, dosage, strengths, gsk, avandamet
Article | 20 September 2004
UK drug major GlaxoSmithKline says the European Commission hasapproved two new dosage strengths of its Avandamet, a treatment for
type 2 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 September 2004
23 May 2013
© 2013 thepharmaletter.com